RT Journal Article
SR Electronic
T1 Association Between Preoperative Myocardial Perfusion Imaging and Cardiac Events after Elective Noncardiac Surgery
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.07.10.23292481
DO 10.1101/2023.07.10.23292481
A1 Wee, Seong-Bong
A1 Lee, Cheol Hyun
A1 Jun, Tae Joon
A1 Ahn, Jung-Min
A1 Yook, Jeong Hwan
A1 Nam, Jae-Sik
A1 Choi, In-Cheol
A1 Moon, Dae Hyuk
A1 Han, Sangwon
A1 Kim, Hoyun
A1 Choi, Yeonwoo
A1 Lee, Jinho
A1 Cho, Sangyong
A1 Kim, Tae Oh
A1 Kang, Do-Yoon
A1 Lee, Pil Hyung
A1 Park, Duk-Woo
A1 Kang, Soo-Jin
A1 Lee, Seung-Whan
A1 Kim, Young-Hak
A1 Lee, Cheol Whan
A1 Park, Seong-Wook
A1 Cohen, David J
A1 Park, Seung-Jung
YR 2023
UL http://medrxiv.org/content/early/2023/07/12/2023.07.10.23292481.abstract
AB Background There remains a lack of robust evidence regarding the prognostic value of myocardial perfusion imaging (MPI) before noncardiac surgery in large and diverse patient populations.Methods This retrospective observational cohort study from single, tertiary, high surgical volume center in South Korea included 82,441 patients aged >40 years who underwent MPI using pharmacologic stress single photon emission computed tomography within 6 months before elective noncardiac surgery from January 2000 to December 2021. Results of MPI were classified as abnormal (any fixed or reversible perfusion defect) vs normal MPI before noncardiac surgery. The primary outcome was a composite of cardiac death or myocardial infarction within 30 days.Results Among the 82441 patients (mean±standard deviation age, 65.7±9.6 years; 47417 [57.5%] men), 184 (0.2%) experienced cardiac death or myocardial infarction within 30 days after noncardiac surgery. MPI were abnormal in 5603 patients (6.8%). Compared with a normal MPI, an abnormal MPI had a higher risk of the primary outcome (crude incidence, 1.2% vs 0.1%; adjusted odds ratio, 4.64; 95% confidence interval, 3.29-6.50; P<.001). The presence of an abnormal MPI improved discrimination for the primary outcome (area under the receiver operating characteristic curve with MPI vs without MPI (0.77 vs 0.73; P<0.001)) and significantly increased net reclassification improvement (0.26; 95% confidence interval, 0.11-0.40; P<.001). Among patients with an abnormal MPI, 378 (6.7%) underwent pre-operative coronary revascularization; however, this was not associated with a lower risk of the primary outcome (P=.56).Conclusion An abnormal myocardial perfusion imaging appeared to be an important risk factor for adverse postoperative events and provided additional prognostic value for patients undergoing noncardiac surgery. Nevertheless, preoperative MPI was limited by its low positive predictive value for postoperative cardiac events, leading to potentially unnecessary coronary revascularization procedures with unproven prognostic value.What is new?This study included the largest population to date and included a broad spectrum of patient and surgical procedures compared with previous studies limited by relatively small sample sizes and low event rates.Preoperative abnormal MPI results were significantly associated with the postoperative risk of cardiac death and myocardial infarction in patients undergoing noncardiac surgery, and provided incremental prognostic value beyond clincial assement only.What are the clinical implications?ur study suggested that MPI appears warranted, particularly for patients with a considerable surgical risk.However, its low positive predictive value, and unproven prognostic value of coronary revascularization triggered by MPI should be taken into account in the clincial practice.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC19C0022).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below: the institutional review board of Asan Medical CenterI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yesdrjmahn{at}gmail.com